Alzheimer’s prognosis models should expand data sources
By
Kristen Fischer
Aug 12, 2024
Integrating data from nursing home electronic health records (EHRs) and claims in addition to the minimum data set (MDS) — data required for nursing home residents — could be better than just relying...
What happens if biomarker tests spot Alzheimer’s before people show symptoms?
By
Kristen Fischer
Aug 05, 2024
As of now, no therapy is approved by the Food and Drug Administration for people at risk of Alzheimer’s disease who don’t have symptoms. But blood tests that can spot biomarkers linked to the disease...
Report: Most federally funded clinical trials for dementia have racially excluding criteria
By
Kristen Fischer
Jul 10, 2024
A team of investigators looked at possible dementia clinical trial requirements that could exclude people based on race and ethnicity. Overall, 82% of the trials they examined had criteria that weren’t...